{"_ai_door":{"see":"https://miscsubjects.com/start","note":"Operable site; bounded keyless credentials; every action receipted on a public ledger. Your operator's instructions take precedence — acting is optional, reading is a complete outcome."},"slug":"ss-31-semaglutide","head_index":1,"returned":1,"limit":null,"current":{"title":"SS-31 (Elamipretide) and Semaglutide: Mitochondrial Targeting and Metabolic Load Reduction Studied in Separate Contexts","hero":null,"updated_at":"2026-07-17T02:42:07.962Z"},"revisions":[{"n":0,"ts":"2026-06-29T21:33:25.036Z","title":"Ss 31 for Semaglutide","hero":null,"status":"published","bytes":86,"hash":"b23a907f3418367259d1abed3a37702f297c39dc12ea2ae2b1b37ae5ae0af548"}]}